Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1006-1014

  Kim, Steven ^a   Lin, Hua ^a   Barr, Eliav ^a   Chu, Lien ^a   Leiden, Jeffrey M ^a   Parmacek, Michael S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adenovirus; Atherosclerosis; Gene therapy; Smooth muscle; Vascular diseases

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TRANSGENE;

EID: 0030883521     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119611     Document Type: Article

References (44)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
2. Nikol, S., T.Y. Huehns, and B. Hofling. 1996. Molecular biology and post-angioplasty restenosis. Atherosclerosis. 123:17-31.
3. Bauters, C. 1995. Gene therapy for cardiovascular diseases. Eur. Heart J. 16:1166-1168.
4. James, A.L., P.D. Pare, and J.C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139:242-246.
5. Ohno, T., D. Gordon, H. San, V.J. Pompili, M.J. Imperiale, G.J. Nabel, and E.G. Nabel. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (Wash. DC). 265:781-784.
6. Chang, M.W., E. Barr, J. Seltzer, Y.-Q. Jiang, G.J. Nabel, E.G. Nabel, M.S. Parmacek, and J.M. Leiden. 1995. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science (Wash. DC). 267:518-522.
7. Guzman, R.J., E.A. Hirschowitz, S.L. Brody, R.G. Crystal, S.E. Epstein, and T. Finkel. 1994. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 91:10732-10736.
8. Flugelman, M.Y. 1995. Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy. Thromb. Haemostasis. 74: 406-410.
9. Muhlhauser, J., M.J. Merrill, R. Pili, H. Maeda, M. Bacic, B. Bewig, A. Passaniti, N.A. Edwards, R.G. Crystal, and M.C. Capogrossi. 1995. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ. Res. 77:1077-1086.
10. Nabel, E.G. 1995. Gene therapy for vascular diseases. Atherosclerosis. 118(Suppl.):S51-S56.
11. Nabel, E.G. 1995. Gene therapy for cardiovascular disease. Circulation. 91:541-548.
12. Yang, Z.Y., R.D. Simari, N.D. Perkins, H. San, D. Gordon, G.J. Nabel, and E.G. Nabel. 1996. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. USA. 93:7905-7910.
13. French, B.A., W. Mazur, N.M. Ali, R.S. Geske, J.P. Finnigan, G.P. Rodgers, R. Roberts, and A.E. Raizner. 1994. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 90:2402-2413.
14. Simari, R.D., H. San, M. Rekhter, T. Ohno, D. Gordon, G.J. Nabel, and E.G. Nabel. 1996. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J. Clin. Invest. 98: 225-235.
15. Haddada, H., L. Cordier, and M. Perricaudet. 1995. Gene therapy using adenovirus vectors. Curr. Top. Microbiol. Immunol. 199:297-306.
16. Simons, M., E.R. Edelman, J.L. DeKeyser, R. Langer, and R.D. Rosenberg. 1992. Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature (Lond.). 359:67-70.
17. Morishita, R., G.H. Gibbons, K.E. Ellison, M. Nakajima, H. von der Leyen, L. Zhang, Y. Kaneda, T. Ogihara, and V.J. Dzau. 1993. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy. Trans. Assoc. Am. Phys. 106:54-61.
18. Kashyap, V.S., S. Santamarina-Fojo, D.R. Brown, C.L. Parrott, D. Applebaum-Bowden, S. Meyn, G. Talley, B. Paigen, N. Maeda, and H.B. Brewer, Jr. 1995. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J. Clin. Invest. 96:1612-1620.
19. Johns, D.C., H.B. Nuss, N. Chiamvimonvat, B.M. Ramza, E. Marban, and J.H. Lawrence. 1995. Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability. J. Clin. Invest. 96:1152-1158.
20. Miller, N., and R. Vile. 1995. Targeted vectors for gene therapy. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:190-199.
21. Chang, M.W., T. Ohno, D. Gordon, M.M. Lu, G.J. Nabel, E.G. Nabel, and J.M. Leiden. 1995. Adenovirus mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon injury of the rat carotid artery. Mol. Med. 1:172-181.
22. March, K.L., J.E. Madison, and B.C. Trapnell. 1995. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 6:41-53.
23. Rajasubramanian, G., R.S. Meidell, C. Landau, M.L. Dollar, D.B. Holt, J.E. Willard, M.D. Prager, and R.C. Eberhart. 1994. Fabrication of resorbable microporous intravascular stents for gene therapy applications. ASAIO (Am. Soc. Artif. Intern. Organs) Trans. 40:M584-M589.
24. Kito, H., T. Suzuki, S. Nagahara, Y. Nakayama, Y. Tsutsui, N. Isutsui, N. Nakajima, and T. Matsuda. 1994. A total delivery system of genetically engineered drugs or cells for diseased vessels. Concept, materials, and fabricated prototype device. ASAIO (Am. Soc. Artif. Intern. Organs) Trans. 40:M260-M266.
25. Krasnykh, V.N., G.V. Mikheeva, J.T. Douglas, and D.T. Curiel. 1996. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70:6839-6846.
26. Schwarzenberger, P., S.E. Spence, J.M. Gooya, D. Michiel, D.T. Curiel, F.W. Ruscetti, and J.R. Keller. 1996. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood. 87:472-478.
27. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
28. Duband, J.L., M. Gimona, M. Scatena, S. Sartore, and J.V. Small. 1993. Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation. 55:1-11.
29. Li, L., J.M. Miano, P. Cserjesi, and E.N. Olson. 1996. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195.
30. Solway, J., J. Seltzer, F.F. Samaha, S. Kim, L.E. Alger, Q. Niu, E.E. Morrisey, H.S. Ip, and M.S. Parmacek. 1995. Structure and expression of a smooth muscle cell-specific gene. SM22α. J. Biol. Chem. 270:13460-13469.
31. Kim, S., H.S. Ip, M.M. Lu, C. Clendenin, and M.S. Parmacek. 1997. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol. Cell. Biol. 17:2266-2278.
32. Tripathy, S.K., E. Goldwasser, M.M. Lu, E. Barr, and J.M. Leiden. 1994. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA. 91:11557-11561.
33. Karpinski, B.A., L.H. Yang, P. Cacheris, G.P. Morle, and J.M. Leiden. 1989. The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol. Cell. Biol. 9:2588-2597.
34. Chang, M.W., E. Barr, M.M. Lu, K. Barton, and J.M. Leiden. 1995. Adenovirus-mediated overexpression of the cyclin/CDK inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of ballon angioplasty. J. Clin. Invest. 96:2260-2268.
35. Barr, E., J. Carroll, A.M. Kalynych, S.K. Tripathy, K. Kozarsky, J.M. Wilson, and J.M. Leiden. 1994. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:51-58.
36. Lin, H., M.S. Parmacek, G. Morle, S. Bolling, and J.M. Leiden. 1990. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 82:2217-2221.
37. Parmacek, M.S., and J.M. Leiden. 1989. Structure and expression of the murine slow/cardiac troponin C gene. J. Biol. Chem. 264:13217-13225.
38. Li, L., J.M. Miano, B. Mercer, and E.N. Olson. 1996. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:849-859.
39. Moessler, H., M. Mericskay, Z. Li, S. Nagl, D. Paulin, and J.V. Small. 1996. The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development. 122: 2415-2425.
40. Nabel, E.G., Z. Yang, S. Liptay, H. San, D. Gordon, C.C. Haudenschild, and G.J. Nabel. 1993. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J. Clin. Invest. 91:1822-1829.
41. Nabel, E.G., L. Shum, V.J. Pompili, Z.Y. Yang, H. San, H.B. Shu, S. Liptay, L. Gold, D. Gordon, and R. Derynck. 1993. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:10759-10763.
42. Nabel, E.G., Z.Y. Yang, G. Plautz, R. Forough, X. Zhan, C.C. Haudenschild, T. Maciag, and G.J. Nabel. 1993. Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature (Lond.). 362:844-846.
43. Pompili, V.J., D. Gordon, H. San, Z. Yang, D.W. Muller, G.J. Nabel, and E.G. Nabel. 1995. Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler. Thromb. Vasc. Biol. 15:2254-2264.
44. Arbuthnot, P.B., M.P. Bralet, C. Le Jossic, J.F. Dedieu, M. Perricaudet, C. Brechot, and N. Ferry. 1996. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum. Gene Ther. 7: 1503-1514.